Molecules and Cells

Korean Society for Molecular and Cellular Biology (한국분자세포생물학회)
권호 표지
DOI QR코드

DOI QR Code

miR-101 Inhibiting Cell Proliferation, Migration and Invasion in Hepatocellular Carcinoma through Downregulating Girdin

  • Cao, Ke (Department of Oncology, Third Xiangya Hospital, Central South University) ;
  • Li, Jingjing (Department of Pathology, Xiangya Basic Medical College, Central South University) ;
  • Zhao, Yong (Department of Oncology, Third Xiangya Hospital, Central South University) ;
  • Wang, Qi (Department of Oncology, Third Xiangya Hospital, Central South University) ;
  • Zeng, Qinghai (Department of Plastic Surgery, Third Xiangya Hospital, Central South University) ;
  • He, Siqi (Department of Oncology, Third Xiangya Hospital, Central South University) ;
  • Yu, Li (Department of Oncology, Third Xiangya Hospital, Central South University) ;
  • Zhou, Jianda (Department of Plastic Surgery, Third Xiangya Hospital, Central South University) ;
  • Cao, Peiguo (Department of Oncology, Third Xiangya Hospital, Central South University)
  • Received : 2015.06.03
  • Accepted : 2015.10.14
  • Published : 2016.02.29
Download PDF
⟨ Previous Next ⟩

Abstract

miR-101 is considered to play an important role in hepatocellular carcinoma (HCC), but the underlying molecular mechanism remains to be elucidated. Here, we aimed to confirm whether Girdin is a target gene of miR-101 and determine the tumor suppressor of miR-101 through Girdin pathway. In our previous studies, we firstly found Girdin protein was overexpressed in HCC tissues, and it closely correlated to tumor size, T stage, TNM stage and Edmondson-Steiner stage of HCC patients. After specific small interfering RNA of Girdin was transfected into HepG2 and Huh7.5.1 cells, the proliferation and invasion ability of tumor cells were significantly inhibited. In this study, we further explored the detailed molecular mechanism of Girdin in HCC. Interestingly, we found that miR-101 significantly low-expressed in HCC tissues compared with that in matched normal tissues while Girdin had a relative higher expression, and miR-101 was inversely correlated with Girdin expression. In addition, after miR-101 transfection, the proliferation, migration and invasion abilities of HepG2 cells were weakened. Furthermore, we confirmed that Girdin is a direct target gene of miR-101. Finally we confirmed Talen-mediated Girdin knockout markedly suppressed cell proliferation, migration and invasion in HCC while downregulation of miR-101 significantly restored the inhibitory effect. Our findings suggested that miR-101/Girdin axis could be a potential application of HCC treatment.

Keywords

References

  1. Anai, M., Shojima, N., Katagiri, H., Ogihara, T., Sakoda, H., Onishi, Y., Ono H., Fujishiro, M., Fukushima, Y., Horike, N., et al. (2005). A novel protein kinase b (pkb)/akt-binding protein enhances pkb kinase activity and regulates DNA synthesis. J. Biol. Chem. 280, 18525-18535. https://doi.org/10.1074/jbc.M500586200
  2. Cao, K., Jiang, W., Cao, P., Zou, Q., Xiao, S., Zhou, J., and Huang, C. (2014). Talen-mediated girdin knockout downregulates cell proliferation, migration and invasion in human esophageal carcinoma eca109 cells. Mol. Med. Rep. 10, 848-854. https://doi.org/10.3892/mmr.2014.2268
  3. Cao, K., Lu, C., Han, S., Zou, Q., Li, J., Xie, D., He, S., Yu, L., Zhou, J., Peng, X., et al. (2015). Expression of Girdin in primary hepatocellular carcinoma and its effect on cell proliferation and invasion. Int. J. Clin. Exp. Pathol. 8, 551-559.
  4. Enomoto, A., Murakami, H., Asai, N., Morone, N., Watanabe, T., Kawai, K., Murakumo, Y., Usukura, J., Kaibuchi, K., and Takahashi, M. (2005). Akt/pkb regulates actin organization and cell motility via girdin/ape. Dev. Cell. 9, 389-402. https://doi.org/10.1016/j.devcel.2005.08.001
  5. Jin, F., Liu, C., Guo, Y., Chen, H., and Wu, Y. (2013). Clinical implications of Girdin and PI3K protein expression in breast cancer. Oncol Lett. 5,1549-1553. https://doi.org/10.3892/ol.2013.1249
  6. Kim, K., Kim, J.H., Kim, I., Lee, J., Seong, S., Park, Y.W., and Kim, N. (2015). MicroRNA-26a regulates RANKL-induced osteoclast formation. Mol. Cells 38, 75-80.
  7. Landgraf, P., Rusu, M., Sheridan, R., Sewer, A., Iovino, N., Aravin, A., Pfeffer, S., Rice, A., Kamphorst, A.O., Landthaler, M., et al. (2007). A mammalian microrna expression atlas based on small RNA library sequencing. Cell 129, 1401-1414. https://doi.org/10.1016/j.cell.2007.04.040
  8. Le-Niculescu, H., Niesman, I., Fischer, T., DeVries, L., and Farquhar, M.G. (2005). Identification and characterization of GIV, a novel Galpha i/s-interacting protein found on COPI, endoplasmic reticulum- Golgi transport vesicles. J. Biol. Chem. 280, 22012- 22020. https://doi.org/10.1074/jbc.M501833200
  9. Lin, X., Guan, H., Li, H., Liu, J., Wei, G., Huang, Z., Liao, Z., and Li, Y. (2014). MiR-101 inhibits cell proliferation by targeting rac1 in papillary thyroid carcinoma. Biomed. Rep. 2, 122-126. https://doi.org/10.3892/br.2013.192
  10. Peng, X., Cao, P., Li, J., He, D., Han, S., Zhou, J., Tan, G., Li, W., Yu, F., Yu, J., et al. (2015). MiR-1204 sensitizes nasopharyngeal carcinoma cells to paclitaxel both in vitro and in vivo. Cancer Biol Ther 16, 261-267. https://doi.org/10.1080/15384047.2014.1001287
  11. Siegel, R., Naishadham, D., and Jemal A. (2012). Cancer statistics, 2013. CA. Cancer. J. Clin. 62,10-29. https://doi.org/10.3322/caac.20138
  12. Shen, Q., Bae, H.J., Eun, J.W., Kim, H.S., Park, S.J., Shin, W.C., Lee, E.K., Park, S., Park, W.S., Lee, J.Y., et al. (2014). MiR-101 functions as a tumor suppressor by directly targeting nemo-like kinase in liver cancer. Cancer. Lett. 344, 204-211. https://doi.org/10.1016/j.canlet.2013.10.030
  13. Shibata, T., Matsuo, Y., Shamoto, T., Hirokawa, T., Tsuboi, K., Takahashi, H., Ishiguro, H., Kimura, M., Takeyama, H., and Inagaki, H. (2013). Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma. Oncol. Rep. 29, 2127-2132. https://doi.org/10.3892/or.2013.2406
  14. Simpson, F., Martin, S., Evans, TM., Kerr, M., James, D.E., Parton, R.G., Teasdale, R.D., and Wicking, C. (2005). A novel hookrelated protein family and the characterization of hook-related protein 1. Traffic 6. 442-458. https://doi.org/10.1111/j.1600-0854.2005.00289.x
  15. Su, H., Yang, J.R., Xu, T., Huang, J., Xu, L., Yuan, Y., and Zhuang, S.M. (2009). MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res. 69, 1135-1142.
  16. Tameda, M., Sugimoto, K., Shiraki, K., Yamamoto, N., Okamoto, R., Usui, M., Ito, M., Takei, Y., Nobori, T., Kojima, T., et al. (2014). Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility. Int. J. Oncol. 45, 541-548. https://doi.org/10.3892/ijo.2014.2445
  17. Wang, C., Lin, J., Li, L., and Wang, Y. (2014). Expression and clinical significance of girdin in gastric cancer. Mol. Clin. Oncol. 2, 425-428. https://doi.org/10.3892/mco.2014.265
  18. Xu, X., Chen, H., Lin, Y., Hu, Z., Mao, Y., Wu, J., Xu, X., Zhu, Y., Li, S., Zheng, X., et al. (2013). MicroRNA-409-3p inhibits migration and invasion of bladder cancer cells via targeting c-Met. Mol. Cells. 36, 62-68. https://doi.org/10.1007/s10059-013-0044-7
  19. Yin, J., Wang, M., Jin, C., and Qi, Q. (2014). miR-101 sensitizes A549 NSCLC cell line to CDDP by activating caspase 3- dependent apoptosis. Oncol. Lett. 7, 461-465. https://doi.org/10.3892/ol.2013.1725
  20. Zhang, J., Han, C., Zhu, H., Song, K., and Wu, T. (2013). MiR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF). Am. J. Pathol. 182, 1629-1639. https://doi.org/10.1016/j.ajpath.2013.01.045
  21. Zhang, Y.J., Li, A.J., Han, Y., Yin, L., and Lin, M.B. (2014). Inhibition of Girdin enhances chemosensitivity of colorectal cancer cells to oxaliplatin. World J Gastroenterol. 20, 8229-8236. https://doi.org/10.3748/wjg.v20.i25.8229
  22. Zheng, C., Li, J., Wang, Q., Liu, W., Zhou, J., Liu, R., Zeng, Q., Peng, X., Huang, C., Cao P., et al. (2015). MicroRNA-195 functions as a tumor suppressor by inhibiting CBX4 in hepatocellular carcinoma. Oncol. Rep. 33, 1115-1122. Z https://doi.org/10.3892/or.2015.3734
  23. hou, L., Yang, Z.X., Song, WJ., Li, QJ., Yang, F., Wang, D.S., Zhang, N., and Dou, K.F. (2013). Microrna-21 regulates the migration and invasion of a stem-like population in hepatocellular carcinoma. Int. J. Oncol. 43, 661-669. https://doi.org/10.3892/ijo.2013.1965

Cited by

  1. Scutellarin suppresses migration and invasion of human hepatocellular carcinoma by inhibiting the STAT3/Girdin/Akt activity vol.483, pp.1, 2017, https://doi.org/10.1016/j.bbrc.2016.12.114
  2. Discs large homolog 5 decreases formation and function of invadopodia in human hepatocellular carcinoma via Girdin and Tks5 vol.141, pp.2, 2017, https://doi.org/10.1002/ijc.30730
  3. New Insights into the Epigenetics of Hepatocellular Carcinoma vol.2017, 2017, https://doi.org/10.1155/2017/1609575
  4. miR-101 suppresses HBV replication and expression by targeting FOXO1 in hepatoma carcinoma cell lines vol.487, pp.1, 2017, https://doi.org/10.1016/j.bbrc.2017.03.171
  5. A prognostic model for lung adenocarcinoma patient survival with a focus on four miRNAs vol.14, pp.3, 2017, https://doi.org/10.3892/ol.2017.6481
  6. Diagnostic and prognostic implications of serum miR-101 in osteosarcoma vol.22, pp.1, 2016, https://doi.org/10.3233/cbm-171103
  7. Circulating miR-106b-3p, miR-101-3p and miR-1246 as diagnostic biomarkers of hepatocellular carcinoma vol.9, pp.20, 2016, https://doi.org/10.18632/oncotarget.24601
  8. miR-193b and miR-30c-1 * inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro vol.9, pp.65, 2016, https://doi.org/10.18632/oncotarget.25986
  9. Circulating microRNAs as Potential Diagnostic and Prognostic Biomarkers in Hepatocellular Carcinoma vol.9, pp.None, 2019, https://doi.org/10.1038/s41598-019-46872-8
  10. miR-101 regulates cell proliferation and apoptosis by targeting KDM1A in diffuse large B cell lymphoma vol.11, pp.None, 2016, https://doi.org/10.2147/cmar.s197744
  11. Long noncoding RNA MEG3 prevents vascular endothelial cell senescence by impairing miR-128-dependent Girdin downregulation vol.316, pp.6, 2016, https://doi.org/10.1152/ajpcell.00262.2018
  12. Long non-coding RNA highly up-regulated in liver cancer protects tumor necrosis factor-alpha-induced inflammatory injury by down-regulation of microRNA-101 in ATDC5 cells vol.72, pp.None, 2016, https://doi.org/10.1016/j.intimp.2019.04.004
  13. MicroRNA dysregulation interplay with childhood abdominal tumors vol.38, pp.4, 2019, https://doi.org/10.1007/s10555-019-09829-x
  14. Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma vol.10, pp.1, 2020, https://doi.org/10.7150/thno.33482
  15. The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma vol.8, pp.None, 2016, https://doi.org/10.3389/fcell.2020.00055
  16. A PTAL-miR-101-FN1 Axis Promotes EMT and Invasion-Metastasis in Serous Ovarian Cancer vol.16, pp.None, 2020, https://doi.org/10.1016/j.omto.2019.12.002
  17. miRNA-101 Targets TGF-βR1 to Retard the Progression of Oral Squamous Cell Carcinoma vol.28, pp.2, 2020, https://doi.org/10.3727/096504019x15761480623959
  18. Quantitative acetylome and phosphorylome analysis reveals Girdin affects pancreatic cancer progression through regulating Cortactin vol.12, pp.9, 2016, https://doi.org/10.18632/aging.103032
  19. Overexpression of miR-101 suppresses collagen synthesis by targeting EZH2 in hypertrophic scar fibroblasts vol.9, pp.None, 2016, https://doi.org/10.1093/burnst/tkab038
  20. XIAP, commonly targeted by tumor suppressive miR-3607-5p and miR-3607-3p, promotes proliferation and inhibits apoptosis in hepatocellular carcinoma vol.113, pp.3, 2016, https://doi.org/10.1016/j.ygeno.2021.02.003
  21. Crosstalk between miR‐203 and PKCθ regulates breast cancer stem cell markers vol.85, pp.3, 2021, https://doi.org/10.1111/ahg.12415